Suat Erdogan

16PUBLICATIONS
9CO-AUTHORS
Molecular targetsPredictive and prognostic markersEpidemiological modellingMolecular medicineCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 26, 2026
Co-treatment with pyrvinium pamoate and hispidulin potently reduces stemness and promotes mitochondrial apoptosis in prostate cancer cells.

|Apr 09, 2026
Targeted elimination of CD44+ prostate cancer stem cells using hyaluronic acid-coated selenium nanoparticles co-loaded with apigenin.

Sinan Vicil, Riza Serttas, Suat Erdogan

|Sep 24, 2025
Esculetin inhibits TGF-β2-induced proliferation and epithelial-mesenchymal transition of retinal pigment epithelial cells.

Abdulkadir Can Çınar, Ayça Küpeli Çınar, Riza Serttas

|Nov 29, 2024
As shown hesperidin suppresses TGF-β2-induced proliferation and epithelial-mesenchymal transition of retinal pigment epithelial cells.

Ayça Küpeli Çınar, Riza Serttas, Abdulkadir Can Çınar

|Mar 14, 2024
Multifaceted impact of adipose conditioned media: Obesity-driven promotion of prostate cancer and cancer stem cell dynamics.

Suat Erdogan, Riza Serttas, Ilker Dibirdik

|Jan 11, 2024
Potent Suppression of Prostate Cancer Cell Growth and Eradication of Cancer Stem Cells by CD44-targeted Nanoliposome-quercetin Nanoparticles.

Kader Turkekul, Suat Erdogan

Pageof 3

Frequent Collaborators

9 joint publications

Riza Serttas

5 joint publications

Kader Turkekul

3 joint publications

Ayça Küpeli Çınar

2 joint publications

Sadik Altan Ozal